[Immunologic study of cirrhotic disease. Statistical analysis of 106 cases].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 5309774)

Published in Rev Eur Etud Clin Biol on January 01, 1970

Authors

J P Nakache, D Salmon, F Grémy, A Gerbal, J C Homberg, C Salmon, H Rochant, Y Hecht, J Caroli

Articles by these authors

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79

The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92

Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J Virol (1999) 2.72

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41

The genes and transcripts of an antigen gene expression site from T. brucei. Cell (1989) 2.36

Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients. Am J Med (1993) 2.02

[Does a probability of paternity exist?]. Med Leg Dommage Corpor (1972) 1.99

Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol (1992) 1.93

The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91

Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75

Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology (1993) 1.71

Morpho-semantic analysis and translation of medical compound terms. Methods Inf Med (1991) 1.70

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS (2001) 1.63

Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol (1988) 1.62

Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr (1990) 1.61

Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J Hepatol (2000) 1.58

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A (1988) 1.57

Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci U S A (1990) 1.52

Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med (1985) 1.52

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) (1999) 1.51

Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS (1999) 1.51

A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5. Clin Exp Immunol (1978) 1.49

Seroimmunologic classification of chronic hepatitis in 57 children. Hepatology (1983) 1.48

Polymerase chain reaction testing of HIV-1 seronegative at-risk individuals. Lancet (1990) 1.46

[Drying of cirrhotic ascites by continuous intravenous reinjection of concentrated ascitic fluid]. Ann Med Interne (Paris) (1971) 1.46

Longitudinal study of associations between perceived health status and self reported diseases in the French Gazel cohort. J Epidemiol Community Health (2001) 1.46

[Indicators of health and "sanometrie": conceptual aspects of recent research on measuring the state of health of a population. 2]. Rev Epidemiol Sante Publique (1979) 1.43

Tumor necrosis factor and resting energy expenditure during the acquired immunodeficiency syndrome. Am J Clin Nutr (1993) 1.40

Probability of paternity. Am J Hum Genet (1976) 1.39

Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol (1993) 1.39

Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit. J Hosp Infect (1995) 1.39

[Local tolerance of subcutaneous heparin. Double-blind comparison of calcium and sodium heparins (author's transl)]. Sem Hop (1979) 1.39

Chronic active hepatitis associated with liver-kidney microsomal antibody of an autoimmune type. Two familial cases. Dig Dis Sci (1986) 1.39

[Reactivation of hepatitis B in AIDS]. Presse Med (1995) 1.37

Acute renal failure after rifampicin. Lancet (1972) 1.36

Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol (1974) 1.33

Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.31

Down-regulation of TSH subunit mRNA levels by thyroid hormones in the European eel. Gen Comp Endocrinol (1997) 1.30

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30

Varicella in patients infected with the human immunodeficiency virus. Arch Dermatol (1990) 1.28

Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) (1999) 1.28

[48, XXXX syndrome in a six year old child. Abnormal transmission of group Xg]. Ann Genet (1968) 1.26

A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol (1984) 1.25

Diseases of the intrahepatic biliary tree. Clin Gastroenterol (1973) 1.24

Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res (1983) 1.23

Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology (2007) 1.22

Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet (1988) 1.21

Clinical significance of mitochondrial antibodies in relation to liver disease. Lancet (1981) 1.21

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology (1988) 1.21

Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models. J Int Neuropsychol Soc (2001) 1.20

Sensitivity to rifampicin: incidence, mechanism, and prevention. Br Med J (1974) 1.20

Tk polyagglutination produced in vitro by an endo-beta-galactosidase. Vox Sang (1980) 1.20

Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr (1986) 1.19

French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers. Ann Rheum Dis (2003) 1.18

Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology (1987) 1.18

A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis. Clin Exp Immunol (1982) 1.17

High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis. BMJ (1994) 1.16

A peripheral protein associated with the cis-Golgi network redistributes in the intermediate compartment upon brefeldin A treatment. J Cell Biol (1994) 1.16

Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr (1993) 1.15

Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients. Postgrad Med J (1975) 1.12

Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004. Euro Surveill (2008) 1.11

Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A (1987) 1.10

Demonstration of T-transferase deficiency in Tn-polyagglutinable blood samples. Eur J Biochem (1978) 1.10

[Estimation of probability of paternity from blood groups and genetic markers (author's transl)]. Nouv Rev Fr Hematol (1975) 1.10

Anti-nomifensine antibody causing immune hemolytic anemia and renal failure. Vox Sang (1981) 1.09

Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr (1991) 1.09

Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia. Br J Haematol (1969) 1.08

Blood groups and genetic markers polymorphism and probability of paternity. Transfusion (1981) 1.08

Challenges and opportunities for technology assessment in medical informatics. Report of a MEDINFO '92 workshop. Med Inform (Lond) (1994) 1.08

[Refractory anemias: acquired enzymopathies of hematopoietic stem cells]. Nouv Rev Fr Hematol (1969) 1.08

Determination of the N-terminal sequence of human red cell Rh(D) polypeptide and demonstration that the Rh(D), (c), and (E) antigens are carried by distinct polypeptide chains. Blood (1988) 1.08

[Respiratory function and the rheological status of bronchial secretions collected by spontaneous expectoration and after physiotherapy (author's transl)]. Bull Physiopathol Respir (Nancy) (1974) 1.08

An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. J Infect Dis (1989) 1.07

[Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment]. Nouv Presse Med (1975) 1.07

Ethical problems in health information systems. Methods Inf Med (2001) 1.07

Liver biopsy and prognosis in acute liver failure. Gut (1973) 1.06

Regulation of transferrin receptors in human hematopoietic cell lines. J Biol Chem (1984) 1.06

T-cell lymphoma revealed by a peripheral neuropathy. A report of two cases with an immunohistologic study on lymph node and nerve biopsies. Cancer (1986) 1.05

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology (1999) 1.05

Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum. Infect Immun (1986) 1.05

[Bi-allelic genetic markers and the determination of family relationships]. C R Acad Sci Hebd Seances Acad Sci D (1976) 1.05

Development and assessment of DArT markers in triticale. Theor Appl Genet (2011) 1.05

Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology (2003) 1.05

[Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases]. Rev Med Interne (2002) 1.04

'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individuals. Clin Endocrinol (Oxf) (1985) 1.04

Autoimmune hemolytic anemia in children. A review of 80 cases. Am J Med (1974) 1.03

Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology (1985) 1.03

Assay of alpha-N-acetylgalactosaminyltransferases in human sera. Further evidence for several types of Am individuals. Vox Sang (1975) 1.03

Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation. Epidemiol Infect (2006) 1.02

Clonidine hallucinations. Ann Intern Med (1980) 1.02